Creating a better clinical development strategy for rare diseases through AI innovation with inClude

What’s Inside?

To help rare disease innovators establish a better clinical development strategy, Volv is conducting an in-depth Workshop at the World Orphan Drug Congress (WODC) USA, which is being held in Boston from 11th to 13th July 2022.

Volv's Workshop on 11th July 2022 at 15:00 will cover the launch of inClude our most recent AI tool:

• Helps sponsors identify the target patient population among both diagnosed and undiagnosed rare disease patients.
• Establish clinical outcome assessments that characterise earlier disease states and can be considered as novel endpoints in clinical trials.
• Expand the range of biomarkers to advance biological understanding of the disease.
  Come and join in the discussion at our Workshop. We need your feedback.